OSTEOSARCOMA

This adverse event was reported 385 times

OSTEOSARCOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DEXRAZOXANE FOR INJECTION 12 0.0127
1 POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS 1 0.0055
2 THIOTEPA 28 0.0029
3 DACTINOMYCIN 5 0.0023
4 IFOSFAMIDE FOR INJECTION 48 0.0022
5 TALIGLUCERASE ALFA 1 0.0017
6 PEXIDARTINIB HYDROCHLORIDE 1 0.0014
7 DINUTUXIMAB 1 0.0012
8 INFLIXIMAB-DYYB 4 0.0012
9 LAROTRECTINIB 1 0.0011
See all drugs enriched for association with OSTEOSARCOMA